Retinopathy Of Prematurity Zone Iii C4703700
The mildest stage of ROP affecting the peripheral retina in premature infants. Most cases resolve without treatment but require monitoring.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Retinal detachment
Abnormal retinal vascularization
(ophthalmologic)Generalized symptoms
(ophthalmologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Peripheral retinal changes
(ophthalmologic)Zone III retinopathy findings
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dilated fundus examination screening
Regular screening examinations with pupil dilation to detect progression from zone III ROP to more severe stages requiring intervention.
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Peripheral laser photocoagulation
Laser ablation of the peripheral avascular retina to reduce vascular endothelial growth factor production and prevent progression.
Additional treatment options
Intravitreal anti-VEGF agents
Targeted injection of bevacizumab or ranibizumab to suppress abnormal retinal vessel growth in ROP.
medicationCryotherapy
Application of freezing probe to peripheral retina to destroy avascular zones and reduce VEGF production.
procedureVitreoretinal surgery
Vitrectomy for advanced ROP complications including retinal detachment, providing anatomical reattachment.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Retinopathy Of Prematurity Zone Iii C4703700?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Fierson WM, American Academy of Pediatrics Section on Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018.
Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011.
Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. Surv Ophthalmol. 2012.
Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. 2018.
Medication Comparisons
Compare medications used to treat Retinopathy Of Prematurity Zone Iii C4703700. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy